Profound Medical (PROF) Receivables - Other (2018 - 2026)

Profound Medical's Receivables - Other history runs 9 years deep, the most recent figure standing at $176000.0 for Q1 2026.

• On a quarterly basis, Receivables - Other rose 0.57% year-over-year to $176000.0 in Q1 2026; TTM through Mar 2026 was $176000.0, a 0.57% increase from a year earlier, with the FY2025 full-year figure at $80000.0, down 74.19% from the prior year.
• Receivables - Other climbed to $176000.0 in Q1 2026 per PROF's latest filing, from $80000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $310000.0 in Q4 2024 and bottomed at $13000.0 in Q4 2022.
• The 5-year median for Receivables - Other is $141000.0 (2023), against an average of $143500.0.
• Across the five-year window, Receivables - Other surged 823.08% in 2023 and sank 74.19% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $13000.0 in 2022, then jumped by 823.08% to $120000.0 in 2023, then soared by 158.33% to $310000.0 in 2024, then sank by 74.19% to $80000.0 in 2025, then surged by 120.0% to $176000.0 in 2026.
• Per Business Quant, the three latest PROF Receivables - Other figures stand at $176000.0 (Q1 2026), $80000.0 (Q4 2025), and $112000.0 (Q3 2025).